First Light Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-22,828
| Closed | -$5.43M | – | 69 |
|
2020
Q1 | $5.43M | Sell |
22,828
-3,689
| -14% | -$878K | 0.93% | 29 |
|
2019
Q4 | $5.81M | Sell |
26,517
-98
| -0.4% | -$21.5K | 0.74% | 32 |
|
2019
Q3 | $4.51M | Sell |
26,615
-263
| -1% | -$44.6K | 0.68% | 37 |
|
2019
Q2 | $4.93M | Buy |
26,878
+119
| +0.4% | +$21.8K | 0.68% | 39 |
|
2019
Q1 | $4.92M | Buy |
26,759
+2,144
| +9% | +$394K | 0.64% | 38 |
|
2018
Q4 | $4.08M | Sell |
24,615
-172
| -0.7% | -$28.5K | 0.65% | 36 |
|
2018
Q3 | $4.78M | Sell |
24,787
-187
| -0.7% | -$36K | 0.77% | 29 |
|
2018
Q2 | $4.25M | Buy |
24,974
+1,545
| +7% | +$263K | 0.66% | 32 |
|
2018
Q1 | $3.82M | Buy |
23,429
+372
| +2% | +$60.6K | 0.84% | 31 |
|
2017
Q4 | $3.46M | Sell |
23,057
-364
| -2% | -$54.5K | 0.95% | 31 |
|
2017
Q3 | $3.56M | Buy |
23,421
+302
| +1% | +$45.9K | 1.13% | 29 |
|
2017
Q2 | $2.98M | Sell |
23,119
-6
| -0% | -$773 | 1% | 31 |
|
2017
Q1 | $2.53M | Sell |
23,125
-100
| -0.4% | -$10.9K | 0.97% | 31 |
|
2016
Q4 | $1.71M | Sell |
23,225
-85
| -0.4% | -$6.26K | 0.75% | 35 |
|
2016
Q3 | $2.03M | Sell |
23,310
-525
| -2% | -$45.8K | 0.88% | 38 |
|
2016
Q2 | $2.05M | Sell |
23,835
-441
| -2% | -$37.9K | 0.95% | 36 |
|
2016
Q1 | $1.93M | Sell |
24,276
-44
| -0.2% | -$3.5K | 0.97% | 38 |
|
2015
Q4 | $3.06M | Sell |
24,320
-323
| -1% | -$40.6K | 1.28% | 31 |
|
2015
Q3 | $2.57M | Buy |
24,643
+3,545
| +17% | +$369K | 1.27% | 31 |
|
2015
Q2 | $2.61M | Buy |
21,098
+1,733
| +9% | +$214K | 1.23% | 30 |
|
2015
Q1 | $2.28M | Buy |
19,365
+1,774
| +10% | +$209K | 1.17% | 32 |
|
2014
Q4 | $2.09M | Buy |
17,591
+1,306
| +8% | +$155K | 1.18% | 29 |
|
2014
Q3 | $1.83M | Buy |
16,285
+436
| +3% | +$49K | 1.25% | 27 |
|
2014
Q2 | $1.5M | Buy |
15,849
+859
| +6% | +$81.4K | 1.01% | 37 |
|
2014
Q1 | $1.06M | Buy |
14,990
+1,971
| +15% | +$139K | 0.75% | 39 |
|
2013
Q4 | $967K | Buy |
+13,019
| New | +$967K | 0.82% | 36 |
|